Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A machine learning-enhanced methodology for accurate prediction of enzyme-substrate selection

ABSTRACT: Dataset supporting the identification of machine learning-lead validation of SET8 substrates using targeted mass spectrometry (PRM-MS).

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Kyle K. Biggar

PROVIDER: PXD050037 | JPOST Repository | Sat Feb 22 00:00:00 GMT 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Normalization_Skyline%20Results%20File.skyd	Other
	SET8OE_normalization.raw	Raw
	SET8_OE_substrate_list.raw	Raw
	Targeted%20Kme%20Sites_Skyline%20Results%20File.skyd	Other
	Transition%20list.csv	Csv

Items per page:

1 - 5 of 7

Similar Datasets

Prediction of Breast Cancer Estrogen Receptor Status using Machine Learning

Project description:Gene expression profiles were generated from 199 primary breast cancer patients. Samples 1-176 were used in another study, GEO Series GSE22820, and form the training data set in this study. Sample numbers 200-222 form a validation set. This data is used to model a machine learning classifier for Estrogen Receptor Status. RNA was isolated from 199 primary breast cancer patients. A machine learning classifier was built to predict ER status using only three gene features.

2013-01-01 | E-GEOD-29210 | biostudies-arrayexpress

Prediction of tissue-of-origin of early-stage cancers using serum miRNomes

Project description:Large-scale serum miRNomics in combination with machine learning could lead to the development of a blood-based cancer classification system.

2022-11-12 | GSE211692 | GEO

Prediction of Breast Cancer Estrogen Receptor Status using Machine Learning

2013-01-01 | GSE29210 | GEO

Analysis of the Drosophila and Human DPR Elements Reveals a Distinct Human Variant Whose Specificity Can Be Enhanced by Machine Learning

Project description:The RNA polymerase II core promoter is the site of convergence of the signals that lead to the initiation of transcription. Here, we perform a comparative analysis of the downstream core promoter region (DPR) in Drosophila and humans by using machine learning. These studies revealed a distinct human-specific version of the DPR and led to the use of the machine learning models for the identification of synthetic extreme DPR motifs with specificity for human transcription factors relative to Drosophila factors, and vice versa. More generally, machine learning models could be analogously used to design synthetic promoter elements with customized functional properties.

2023-04-06 | GSE225570 | GEO

Accurate Identification of Sites of Origin in Carcinoma of Unknown Primary (CUP) Tumors Using DNA Methylation I

Project description:53 tumors used in the clinical training and validation of a CUP machine learning classifier using methylation profiling

2025-01-15 | GSE249688 | GEO

Accurate Identification of Sites of Origin in Carcinoma of Unknown Primary (CUP) Tumors Using DNA Methylation II

Project description:53 tumors used in the clinical training and validation of a CUP machine learning classifier using methylation profiling

2025-01-15 | GSE249711 | GEO

Machine learning-based prediction of the activity and specificity of Cas9 variants in gene editing

Project description:Machine learning-based prediction of the activity and specificity of Cas9 variants in gene editing

2024-08-22 | GSE231840 | GEO

DNA-Methylome based Tumor Hypoxia Classifier Identifies HPV-negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence After Primary Radiochemotherapy

Project description:We used machine-learning algorithms to identify a hypoxia-associated methylation signature in patients with HPV negative HNSCC in the TCGA-HNSCC cohort. This current submission forms the basis of the independent validation cohort used to test the Hypoxia-M classifier in our study.

2023-04-05 | E-MTAB-12431 | biostudies-arrayexpress

AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer

Project description:Background: To assist clinicians with diagnosis and optimal treatment decision-making, we attempted to develop and validate an artificial intelligence prediction model for lung metastasis (LM) in colorectal cancer (CRC) patients. Method: The clinicopathological characteristics of 46037 CRC patients from the Surveillance, Epidemiology, and End Results (SEER) database and 2779 CRC patients from a multi-center external validation set were collected retrospectively. After feature selection by univariate and multivariate analyses, six machine learning (ML) models, including logistic regression, K-nearest neighbor, support vector machine, decision tree, random forest, and balanced random forest (BRF), were developed and validated for the LM prediction. The optimization model with best performance was compared to the clinical predictor. In addition, stratified LM patients by risk score were utilized for survival analysis.

| 46649 | ecrin-mdr-crc

Deciphering dermatological distinctions: Cornulin as a discriminant biomarker between Basal Cell Carcinoma and Squamous Cell Carcinoma detected through E-biopsy and Machine Learning

Project description:Background: Clinical misdiagnosis between cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) poses treatment challenges and carries risks of recurrence, metastases, and increased morbidity and mortality. Objective: We aimed to identify discriminant proteins markers for cSCC and BCC using a minimally invasive proteome sampling method called e-biopsy, employing electroporation for non-thermal cell permeabilization and machine learning. Methods: E-biopsy facilitated ex vivo proteome extraction from 21 cSCC and 21 BCC pathologically validated human cancers. LC/MS/MS profiling of 126 proteomes was followed by Machine Learning analysis to identify proteins distinguishing cSCC from BCC. For identified panel validation, we used proteomes sampled by e-biopsy from unrelated 20 cSCC and 46 BCC human cancers, and differential expression analysis of published transcriptomics. The most commonly chosen discriminant biomarker by machine learning models, cornulin, was also validated using fluorescent immunohistochemistry. Results: 192 proteomes sampled from 108 patients were analyzed. Machine Learning-based approaches resulted in a set of 11 potential biomarker proteins that can be used to construct a model with 95.2% average cross-validation accuracy, BCC precision of 93.6±14.5%, cSCC precision of 98.4±7.2%, specificity of 97.7±11.8%, and per-patient sensitivity 92.7±15.3%. Protein-protein interaction analysis revealed a novel interaction network connecting 10 of the 11 resulted proteins. Histological and transcriptomic validation confirmed cornulin as a discriminant marker significantly lower in cSCC than in BCC. Conclusions: E-biopsy combined with machine learning provides a novel approach to molecular biomarkers sampling from skin for biomarker detection and differential expression analysis between cSCC and BCC

2024-08-22 | PXD050713 | Pride